Evidence map›Paper›PMID 38066237›Full record

Trial reportInternational journal of behavioral medicine2025

Self-Monitoring and Self-Efficacy in Patients with Chronic Kidney Disease During Low-Sodium Diet Self-Management Interventions: Secondary Analysis of the ESMO and SUBLIME Trials.

Tiny Hoekstra, Manouk Dam, Gerald Klaassen, Willem Jan W Bos, Paul J M van der Boog, Liffert Vogt, Brigit van Jaarsveld, Sandra van Dijk, Gerjan Navis, Yvette Meuleman and 2 more

Open access · greenAbstract readRandomized Controlled TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in International journal of behavioral medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Tiny HoekstraDepartment of Nephrology, Amsterdam University Medical Centers, VU University Amsterdam, Amsterdam, The Netherlands. t.hoekstra2@amsterdamumc.nl.ORCID http://orcid.org/0009-0001-1845-3564
Manouk DamDepartment of Nephrology, Amsterdam University Medical Centers, VU University Amsterdam, Amsterdam, The Netherlands.
Gerald KlaassenDepartment of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.
Willem Jan W BosDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Paul J M van der BoogDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Liffert VogtAmsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Brigit van JaarsveldDepartment of Nephrology, Amsterdam University Medical Centers, VU University Amsterdam, Amsterdam, The Netherlands.
Sandra van DijkDepartment of Health, Medical, and Neuropsychology, Institute of Psychology, Leiden University, Leiden, The Netherlands.
Gerjan NavisDepartment of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.
Yvette MeulemanDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
ESMO
and SUBLIME study group
Leiden University Medical Center · NLUniversity Medical Center Groningen · NLAmsterdam University Medical Centers · NLLeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with chronic kidney disease are often requested to engage in self-monitoring sodium (i.e. salt) intake, but it is currently unknown how self-monitoring would empower them. This study aims to assess: (1) how frequent self-monitoring tools are being used during low-sodium diet self-management interventions; (2) whether self-efficacy (i.e. trust in own capability to manage the chronic disease) is associated with self-monitoring frequency; and (3) whether higher self-monitoring frequency is associated with an improvement in self-efficacy over time.

methodData from two multicenter randomized controlled trials (ESMO [n = 151] and SUBLIME [n = 99]) among adult Dutch patients with chronic kidney disease (eGFR ≥ 20-25 mL/min/1.73 m

resultsLarge variations in self-monitoring frequency were observed. In both interventions, usage of self-monitoring tools was highest during the first month with sharp drops thereafter. The online food diary was the most frequently used tool. In the ESMO intervention, low baseline self-efficacy was associated with a higher usage frequency of self-monitoring tools. This finding was not confirmed in the SUBLIME intervention. No significant associations were found between usage frequency of self-monitoring tools and changes in self-efficacy over time.

conclusionPatients with low self-efficacy might benefit most from frequent usage of self-monitoring tools when sufficient guidance and support is provided.

Indexed as

Diet, Sodium-RestrictedRenal Insufficiency, ChronicSelf EfficacySelf-ManagementAdultAgedFemaleHumansMaleMiddle AgedChronic kidney diseaseRandomized controlled trialReducing dietary sodium intakeSelf-efficacySelf-managment and lifestyle supportSelf-monitoring tools

Identifiers

PMID38066237
OpenAlexW4389474389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.